Mohsen Bakhshandeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohsen Bakhshandeh has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Bijan Hashemi
Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
10 shared publications - Seied Rabi Mahdavi
Iran University of Medical Sciences
8 shared publications - Amin Banaei
Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
7 shared publications Bahram Mofid
Department of Radiation Oncology, Shohada-e Tajrish Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications- Bahram Mofid
Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 shared publications - Abolfazl Razzaghdoust
Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- Open Access
- 22 May 2024
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 23, e15
Optimizing MRI pulse sequence for displaying gold markers in radiation therapy simulation of patients with prostate cancer
Background: Magnetic resonance localization of gold markers for radiotherapy is critical for the treatment planning of prostatic cancer. This study sought to enhance the visualization of gold markers by applying the three-dimensional gradient echo (3D GRE) T2* sequence and comparing it with CT scan. Methods: 29 Patients who underwent both a 3D GRE T2* sequence and a CT were evaluated by an oncologist and radiologist. The SNR, CNR and prostate volume were calculated. Result: The depiction of gold markers using 3D GRE T2* exhibited an enhanced quality in comparison to CT (p < 0·05). Prostate SNR, fat SNR, muscle SNR and Osteon SNR were found to be elevated in 3D GRE T2*, as opposed to the CT (p < 0·05). The comparison of the average prostate volume revealed a significant difference between the mean measurements (sig = 0, p < 0·05). The prostate Volume in 3D GRE T2* 29·03% smaller in magnitude when compared to the CT, thus bringing it into closer alignment with its authentic dimensions. Conclusion: The comparison between the MRI and the CT demonstrated that 3D GRE T2* is an exceptional tool for visualizing gold markers in the realm of prostate cancer radiotherapy planning. It has the potential to minimize collateral damage to healthy cells while enhancing the precision of cancer cell targeting.
- 22 May 2024
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 23, e15
Open AccessOptimizing MRI pulse sequence for displaying gold markers in radiation therapy simulation of patients with prostate cancer
Background: Magnetic resonance localization of gold markers for radiotherapy is critical for the treatment planning of prostatic cancer. This study sought to enhance the visualization of gold markers by applying the three-dimensional gradient echo (3D GRE) T2* sequence and comparing it with CT scan. Methods: 29 Patients who underwent both a 3D GRE T2* sequence and a CT were evaluated by an oncologist and radiologist. The SNR, CNR and prostate volume were calculated. Result: The depiction of gold markers using 3D GRE T2* exhibited an enhanced quality in comparison to CT (p < 0·05). Prostate SNR, fat SNR, muscle SNR and Osteon SNR were found to be elevated in 3D GRE T2*, as opposed to the CT (p < 0·05). The comparison of the average prostate volume revealed a significant difference between the mean measurements (sig = 0, p < 0·05). The prostate Volume in 3D GRE T2* 29·03% smaller in magnitude when compared to the CT, thus bringing it into closer alignment with its authentic dimensions. Conclusion: The comparison between the MRI and the CT demonstrated that 3D GRE T2* is an exceptional tool for visualizing gold markers in the realm of prostate cancer radiotherapy planning. It has the potential to minimize collateral damage to healthy cells while enhancing the precision of cancer cell targeting.
- Open Access
- 23 November 2022
- Published by Springer Nature in Radiation Oncology
- Vol. 17 (1) , 1-10
Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images
Dose painting planning would be more complicated due to different levels of prescribed doses and more complex evaluation with conventional plan quality indices considering uniform dose prescription. Therefore, we tried to introduce new indices for evaluating the dose distribution conformity and homogeneity of treatment volumes based on the tumoral cell density and relative volumes of each lesion in prostate IMRT. CT and MRI scans of 20 male patients having local prostate cancer were used for IMRT DP planning. Apparent diffusion coefficient (ADC) images were imported to a MATLAB program to identify lesion regions based on ADC values automatically. Regions with ADC values lower than 750 mm2/s and regions with ADC values higher than 750 and less than 1500 mm2/s were considered CTV70Gy (clinical tumor volume with 70 Gy prescribed dose), and CTV60Gy, respectively. Other regions of the prostate were considered as CTV53Gy. New plan evaluation indices based on evaluating the homogeneity (IOE(H)), and conformity (IOE(C)) were introduced, considering the relative volume of each lesion and cellular density obtained from ADC images. These indices were compared with conventional homogeneity and conformity indices and IOEs without considering cellular density. Furthermore, tumor control probability (TCP) was calculated for each patient, and the relationship of the assessed indices were evaluated with TCP values. IOE (H) and IOE (C) with considering cellular density had significantly lower values compared to conventional indices and IOEs without considering cellular density. (P < 0.05). TCP values had a stronger relationship with IOE(H) considering cell density (R2 = -0.415), and IOE(C) without considering cell density (R2 = 0.624). IOE plan evaluation indices proposed in this study can be used for evaluating prostate IMRT dose painting plans. We suggested to consider cell densities in the IOE(H) calculation formula and it’s appropriate to calculate IOE(C) without considering cell density values.
- 23 November 2022
- Published by Springer Nature in Radiation Oncology
- Vol. 17 (1) , 1-10
Open AccessIntroducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images
Dose painting planning would be more complicated due to different levels of prescribed doses and more complex evaluation with conventional plan quality indices considering uniform dose prescription. Therefore, we tried to introduce new indices for evaluating the dose distribution conformity and homogeneity of treatment volumes based on the tumoral cell density and relative volumes of each lesion in prostate IMRT. CT and MRI scans of 20 male patients having local prostate cancer were used for IMRT DP planning. Apparent diffusion coefficient (ADC) images were imported to a MATLAB program to identify lesion regions based on ADC values automatically. Regions with ADC values lower than 750 mm2/s and regions with ADC values higher than 750 and less than 1500 mm2/s were considered CTV70Gy (clinical tumor volume with 70 Gy prescribed dose), and CTV60Gy, respectively. Other regions of the prostate were considered as CTV53Gy. New plan evaluation indices based on evaluating the homogeneity (IOE(H)), and conformity (IOE(C)) were introduced, considering the relative volume of each lesion and cellular density obtained from ADC images. These indices were compared with conventional homogeneity and conformity indices and IOEs without considering cellular density. Furthermore, tumor control probability (TCP) was calculated for each patient, and the relationship of the assessed indices were evaluated with TCP values. IOE (H) and IOE (C) with considering cellular density had significantly lower values compared to conventional indices and IOEs without considering cellular density. (P < 0.05). TCP values had a stronger relationship with IOE(H) considering cell density (R2 = -0.415), and IOE(C) without considering cell density (R2 = 0.624). IOE plan evaluation indices proposed in this study can be used for evaluating prostate IMRT dose painting plans. We suggested to consider cell densities in the IOE(H) calculation formula and it’s appropriate to calculate IOE(C) without considering cell density values.
- 14 July 2022
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 22, 1-13
Dosimetric effect of modelling non-homogeneous LINAC couch using cone-beam computed tomography on quality assurance (QA) results
Aim: To evaluate the dosimetric effect of modelling a non-homogeneous couch on patients’ quality assurance (QA) gamma pass rates for intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) techniques. Materials and Methods: A non-homogeneous treatment couch (TxT 550 TTM, CIVCO, USA) was imaged using the LINAC mounted cone-beam computer tomography (CBCT) system. Modelling this couch in different situations, including incomplete (homogeneous model), correct model and not defined situations in the treatment planning system (TPS), was performed based on the geometrical and material densities data extracted from the CBCT images. Calculated gamma pass rates between TPS dose calculations and the measurements in a phantom for different couch models were obtained and compared at two gamma criteria (2%-2 mm and 3%-3 mm). Results: Comparing TPS calculations for the correct modelled couch and the measurements showed high gamma pass rates for both the IMRT and VMAT techniques (96·5 ± 0·9%, 99·2 ± 0·5% for IMRT in 2%-2 mm and 3%-3 mm criteria; 97·5 ± 0·8%, 99·4 ± 0·5% for VMAT). The overall gamma pass rate of the IMRT plan QAs was reduced by about 2% and 3% on average for incomplete and no couch modelling, respectively. These reductions for VMAT techniques were 2·5% and 4·3%, respectively. Conclusions: Non-homogeneous couches have different parts with different attenuations, which can be correctly defined using LINAC CBCT. Modelling of treatment couch has a significant effect on patient QA results for VMAT and IMRT plans, especially in radiation fields/subfield transmitting from the couch. We suggest using LINAC CBCTs as an appropriate device for couch modelling in modulated radiotherapy techniques.
- 14 July 2022
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 22, 1-13
Dosimetric effect of modelling non-homogeneous LINAC couch using cone-beam computed tomography on quality assurance (QA) results
Aim: To evaluate the dosimetric effect of modelling a non-homogeneous couch on patients’ quality assurance (QA) gamma pass rates for intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) techniques. Materials and Methods: A non-homogeneous treatment couch (TxT 550 TTM, CIVCO, USA) was imaged using the LINAC mounted cone-beam computer tomography (CBCT) system. Modelling this couch in different situations, including incomplete (homogeneous model), correct model and not defined situations in the treatment planning system (TPS), was performed based on the geometrical and material densities data extracted from the CBCT images. Calculated gamma pass rates between TPS dose calculations and the measurements in a phantom for different couch models were obtained and compared at two gamma criteria (2%-2 mm and 3%-3 mm). Results: Comparing TPS calculations for the correct modelled couch and the measurements showed high gamma pass rates for both the IMRT and VMAT techniques (96·5 ± 0·9%, 99·2 ± 0·5% for IMRT in 2%-2 mm and 3%-3 mm criteria; 97·5 ± 0·8%, 99·4 ± 0·5% for VMAT). The overall gamma pass rate of the IMRT plan QAs was reduced by about 2% and 3% on average for incomplete and no couch modelling, respectively. These reductions for VMAT techniques were 2·5% and 4·3%, respectively. Conclusions: Non-homogeneous couches have different parts with different attenuations, which can be correctly defined using LINAC CBCT. Modelling of treatment couch has a significant effect on patient QA results for VMAT and IMRT plans, especially in radiation fields/subfield transmitting from the couch. We suggest using LINAC CBCTs as an appropriate device for couch modelling in modulated radiotherapy techniques.
- 10 April 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 108, 108737
Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model
- 10 April 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 108, 108737
Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model
- Open Access
- 20 January 2022
- Published by Springer Nature in Radiation Oncology
- Vol. 17 (1) , 1-16
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia
Background: Low dose radiotherapy (LDRT) of whole lungs with photon beams is a novel method for treating COVID-19 pneumonia. This study aimed to estimate cancer risks induced by lung LDRT for different radiotherapy delivery techniques. Method: Four different radiotherapy techniques, including 3D-conformal with anterior and posterior fields (3D-CRT AP–PA), 3D-conformal with 8 coplanar fields (3D-CRT 8 fields), eight fields intensity-modulated radiotherapy (IMRT), and volumetric modulated arc therapy using 2 full arcs (VMAT) were planned on the CT images of 32 COVID-19 patients with the prescribed dose of 1 Gy to the lungs. Organ average and maximum doses, and PTV dose distribution indexes were compared between different techniques. The radiation-induced cancer incidence and cancer-specific mortality, and cardiac heart disease risks were estimated for the assessed techniques. Results: In IMRT and VMAT techniques, heart (mean and max), breast (mean, and max), and stomach (mean) doses and also maximum dose in the body were significantly lower than the 3D-CRT techniques. The calculated conformity indexes were similar in all the techniques. However, the homogeneity indexes were lower (i.e., better) in intensity-modulated techniques (P < 0.03) with no significant differences between IMRT and VMAT plans. Lung cancer incident risks for all the delivery techniques were similar (P > 0.4). Cancer incidence and mortality risks for organs located closer to lungs like breast and stomach were higher in 3D-CRT techniques than IMRT or VMAT techniques (excess solid tumor cancer incidence risks for a 30 years man: 1.94 ± 0.22% Vs. 1.68 ± 0.17%; and women: 6.66 ± 0.81% Vs. 4.60 ± 0.43%: cancer mortality risks for 30 years men: 1.63 ± 0.19% Vs. 1.45 ± 0.15%; and women: 3.63 ± 0.44% Vs. 2.94 ± 0.23%). Conclusion: All the radiotherapy techniques had low cancer risks. However, the overall estimated risks induced by IMRT and VMAT radiotherapy techniques were lower than the 3D-CRT techniques and can be used clinically in younger patients or patients having greater concerns about radiation induced cancers.
- 20 January 2022
- Published by Springer Nature in Radiation Oncology
- Vol. 17 (1) , 1-16
Open AccessEstimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia
Background: Low dose radiotherapy (LDRT) of whole lungs with photon beams is a novel method for treating COVID-19 pneumonia. This study aimed to estimate cancer risks induced by lung LDRT for different radiotherapy delivery techniques. Method: Four different radiotherapy techniques, including 3D-conformal with anterior and posterior fields (3D-CRT AP–PA), 3D-conformal with 8 coplanar fields (3D-CRT 8 fields), eight fields intensity-modulated radiotherapy (IMRT), and volumetric modulated arc therapy using 2 full arcs (VMAT) were planned on the CT images of 32 COVID-19 patients with the prescribed dose of 1 Gy to the lungs. Organ average and maximum doses, and PTV dose distribution indexes were compared between different techniques. The radiation-induced cancer incidence and cancer-specific mortality, and cardiac heart disease risks were estimated for the assessed techniques. Results: In IMRT and VMAT techniques, heart (mean and max), breast (mean, and max), and stomach (mean) doses and also maximum dose in the body were significantly lower than the 3D-CRT techniques. The calculated conformity indexes were similar in all the techniques. However, the homogeneity indexes were lower (i.e., better) in intensity-modulated techniques (P < 0.03) with no significant differences between IMRT and VMAT plans. Lung cancer incident risks for all the delivery techniques were similar (P > 0.4). Cancer incidence and mortality risks for organs located closer to lungs like breast and stomach were higher in 3D-CRT techniques than IMRT or VMAT techniques (excess solid tumor cancer incidence risks for a 30 years man: 1.94 ± 0.22% Vs. 1.68 ± 0.17%; and women: 6.66 ± 0.81% Vs. 4.60 ± 0.43%: cancer mortality risks for 30 years men: 1.63 ± 0.19% Vs. 1.45 ± 0.15%; and women: 3.63 ± 0.44% Vs. 2.94 ± 0.23%). Conclusion: All the radiotherapy techniques had low cancer risks. However, the overall estimated risks induced by IMRT and VMAT radiotherapy techniques were lower than the 3D-CRT techniques and can be used clinically in younger patients or patients having greater concerns about radiation induced cancers.
- Open Access
- 1 January 2022
- Published by CMV Verlag in International Journal of Radiation Research
- Vol. 20 (1) , 185-189
Radiation dose of head and abdomen-pelvis computed tomography examinations using size-specific dose estimate
Background: Concern about radiation risk of computed tomography (CT) scan as a diagnostic modality has increased in recent years. Diagnostic reference levels (DRLs) is one of the tools to optimizing radiation dose of patients. CTDIv (Volume Computed tomography dose index) and DLP (Dose Length product) are used for assessment of DRLs. ...
- 1 January 2022
- Published by CMV Verlag in International Journal of Radiation Research
- Vol. 20 (1) , 185-189
Open AccessRadiation dose of head and abdomen-pelvis computed tomography examinations using size-specific dose estimate
Background: Concern about radiation risk of computed tomography (CT) scan as a diagnostic modality has increased in recent years. Diagnostic reference levels (DRLs) is one of the tools to optimizing radiation dose of patients. CTDIv (Volume Computed tomography dose index) and DLP (Dose Length product) are used for assessment of DRLs. ...
- Open Access
- 20 September 2021
- Published by Springer Nature in Radiation Oncology
- Vol. 16 (1) , 1-16
The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering
Background: We aimed to assess the feasibility of a dose painting (DP) procedure, known as simultaneous integrated boost intensity modulated radiation Therapy (SIB-IMRT), for treating prostate cancer with dominant intraprostatic lesions (DILs) based on multi-parametric magnetic resonance (mpMR) images and hierarchical clustering with a machine learning technique.Methods: The mpMR images of 120 patients were used to create hierarchical clustering and draw a dendrogram. Three clusters were selected for performing agglomerative clustering. Then, the DIL acquired from the mpMR images of 20 patients were categorized into three groups to have them treated with a DP procedure being composed of three planning target volumes (PTVs) determined as PTV1, PTV2, and PTV3 in treatment plans. The DP procedure was carried out on the patients wherein a total dose of 80, 85 and 91 Gy were delivered to the PTV1, PTV2, and PTV3, respectively. Dosimetric and radiobiologic parameters [Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP)] of the DP procedure were compared with those of the conventional IMRT and Three-Dimensional Conformal Radiation Therapy (3DCRT) procedures carried out on another group of 20 patients. A post-treatment follow-up was also made four months after the radiotherapy procedures.Results: All the dosimetric variables and the NTCPs of the organs at risks (OARs) revealed no significant difference between the DP and IMRT procedures. Regarding the TCP of three investigated PTVs, significant differences were observed between the DP versus IMRT and also DP versus 3DCRT procedures. At post-treatment follow-up, the DIL volumes and apparent diffusion coefficient (ADC) values in the DP group differed significantly (p-value < 0.001) from those of the IMRT. However, the whole prostate ADC and prostate-specific antigen (PSA) indicated no significant difference (p-value > 0.05) between the DP versus IMRT.Conclusions: The results of this comprehensive clinical trial illustrated the feasibility of our DP procedure for treating prostate cancer based on mpMR images validated with acquired patients’ dosimetric and radiobiologic assessment and their follow-ups. This study confirms significant potential of the proposed DP procedure as a promising treatment planning to achieve effective dose escalation and treatment for prostate cancer.Trial registration: IRCT20181006041257N1; Iranian Registry of Clinical Trials, Registered: 23 October 2019,https://en.irct.ir/trial/34305.
- 20 September 2021
- Published by Springer Nature in Radiation Oncology
- Vol. 16 (1) , 1-16
Open AccessThe feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering
Background: We aimed to assess the feasibility of a dose painting (DP) procedure, known as simultaneous integrated boost intensity modulated radiation Therapy (SIB-IMRT), for treating prostate cancer with dominant intraprostatic lesions (DILs) based on multi-parametric magnetic resonance (mpMR) images and hierarchical clustering with a machine learning technique.Methods: The mpMR images of 120 patients were used to create hierarchical clustering and draw a dendrogram. Three clusters were selected for performing agglomerative clustering. Then, the DIL acquired from the mpMR images of 20 patients were categorized into three groups to have them treated with a DP procedure being composed of three planning target volumes (PTVs) determined as PTV1, PTV2, and PTV3 in treatment plans. The DP procedure was carried out on the patients wherein a total dose of 80, 85 and 91 Gy were delivered to the PTV1, PTV2, and PTV3, respectively. Dosimetric and radiobiologic parameters [Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP)] of the DP procedure were compared with those of the conventional IMRT and Three-Dimensional Conformal Radiation Therapy (3DCRT) procedures carried out on another group of 20 patients. A post-treatment follow-up was also made four months after the radiotherapy procedures.Results: All the dosimetric variables and the NTCPs of the organs at risks (OARs) revealed no significant difference between the DP and IMRT procedures. Regarding the TCP of three investigated PTVs, significant differences were observed between the DP versus IMRT and also DP versus 3DCRT procedures. At post-treatment follow-up, the DIL volumes and apparent diffusion coefficient (ADC) values in the DP group differed significantly (p-value < 0.001) from those of the IMRT. However, the whole prostate ADC and prostate-specific antigen (PSA) indicated no significant difference (p-value > 0.05) between the DP versus IMRT.Conclusions: The results of this comprehensive clinical trial illustrated the feasibility of our DP procedure for treating prostate cancer based on mpMR images validated with acquired patients’ dosimetric and radiobiologic assessment and their follow-ups. This study confirms significant potential of the proposed DP procedure as a promising treatment planning to achieve effective dose escalation and treatment for prostate cancer.Trial registration: IRCT20181006041257N1; Iranian Registry of Clinical Trials, Registered: 23 October 2019,https://en.irct.ir/trial/34305.
- 14 April 2021
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 21 (4) , 481-486
Acute toxicity of 4-week versus 5-week hypofractionated radiotherapy in localised prostate cancer
Aim: To compare the acute radiation-induced bowel and bladder toxicities of two hypofractionated radiotherapy (HFRT) regimens in localised prostate cancer (PCa).Materials and methods: This trial consists of patients with histologically confirmed stage T1-T3aN0M0 PCa, a prostate-specific antigen concentration of 40 ng/mL or lower, and Eastern Cooperative Oncology Group performance status of 0–2. Participants were randomly assigned (1:1) to 56 Gy in 16 fractions over 4 weeks (arm A) or 70·2 Gy in 26 fractions over 5 weeks (arm B). Acute bowel and bladder toxicities were assessed using Radiation Therapy Oncology Group criteria.Results: Between June 2018 and December 2019, 40 patients were randomly assigned to treatment with 4-week (n = 20) and 5-week HFRT (n = 20). In the third month after completion of radiotherapy, the cumulative incidence of acute bowel and bladder toxicities of arms A and B was 20 versus 5% and 70 versus 85%, respectively. The cumulative incidence of grade 2 or worse bowel and bladder toxicities of the 5-week regimen was non-inferior to 4-week HFRT [bowel toxicity: 5% (arm A) versus 5% (arm B), bladder toxicity: 50% (arm A) versus 60% (arm B), p = 0·52).Findings: The 5-week regimen of HFRT is non-inferior to 4-week HFRT in terms of acute bowel and bladder toxicities.
- 14 April 2021
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 21 (4) , 481-486
Acute toxicity of 4-week versus 5-week hypofractionated radiotherapy in localised prostate cancer
Aim: To compare the acute radiation-induced bowel and bladder toxicities of two hypofractionated radiotherapy (HFRT) regimens in localised prostate cancer (PCa).Materials and methods: This trial consists of patients with histologically confirmed stage T1-T3aN0M0 PCa, a prostate-specific antigen concentration of 40 ng/mL or lower, and Eastern Cooperative Oncology Group performance status of 0–2. Participants were randomly assigned (1:1) to 56 Gy in 16 fractions over 4 weeks (arm A) or 70·2 Gy in 26 fractions over 5 weeks (arm B). Acute bowel and bladder toxicities were assessed using Radiation Therapy Oncology Group criteria.Results: Between June 2018 and December 2019, 40 patients were randomly assigned to treatment with 4-week (n = 20) and 5-week HFRT (n = 20). In the third month after completion of radiotherapy, the cumulative incidence of acute bowel and bladder toxicities of arms A and B was 20 versus 5% and 70 versus 85%, respectively. The cumulative incidence of grade 2 or worse bowel and bladder toxicities of the 5-week regimen was non-inferior to 4-week HFRT [bowel toxicity: 5% (arm A) versus 5% (arm B), bladder toxicity: 50% (arm A) versus 60% (arm B), p = 0·52).Findings: The 5-week regimen of HFRT is non-inferior to 4-week HFRT in terms of acute bowel and bladder toxicities.
- Open Access
- 27 January 2021
- Published by Brieflands in International Journal of Cancer Management
- Vol. 14 (1)
The Effect of Contrast-enhanced Computed Tomography (CT) Scans on the Calculated Dose of Radiotherapy in a Thorax Phantom
Background: Despite the benefits of contrast-enhanced computed tomography (CT) scans in better tumor volume delineation, it can affect the accuracy of dose calculation in radiation therapy. This study examined this effect on a thorax phantom. Objectives: The influence of different variables including the concentrations of the Visipaque contrast media, tumor sizes, and CT scan energies on the dose measurement was examined. Methods: Transparent cylinders containing the contrast media were inserted in the lung area of the phantom and the CT scans were made. Non-enhanced CT scans were also acquired. Treatment planning using 2 opposite fields was performed on the CT scans and the doses were calculated in the treatment planning system. The results of the 2 sets of enhanced and non-enhanced CT scans were compared. Results: The correlation between concentration and the percentage of mean dose of the tumor volume was significant in 2 of the tumor sizes. The differences in the mean doses of the 2 plans were examined and more than 3% increase was observed in higher concentrations of the contrast media. Conclusions: According to this study, the suitable concentration of the contrast media administered and the CT scan energy should be considered. This would help to decrease the discrepancies between the calculated and delivered dose in radiotherapy treatments to a clinically acceptable level. The importance of time delays for CT scans after administration of the contrast media is emphasized.
- 27 January 2021
- Published by Brieflands in International Journal of Cancer Management
- Vol. 14 (1)
Open AccessThe Effect of Contrast-enhanced Computed Tomography (CT) Scans on the Calculated Dose of Radiotherapy in a Thorax Phantom
Background: Despite the benefits of contrast-enhanced computed tomography (CT) scans in better tumor volume delineation, it can affect the accuracy of dose calculation in radiation therapy. This study examined this effect on a thorax phantom. Objectives: The influence of different variables including the concentrations of the Visipaque contrast media, tumor sizes, and CT scan energies on the dose measurement was examined. Methods: Transparent cylinders containing the contrast media were inserted in the lung area of the phantom and the CT scans were made. Non-enhanced CT scans were also acquired. Treatment planning using 2 opposite fields was performed on the CT scans and the doses were calculated in the treatment planning system. The results of the 2 sets of enhanced and non-enhanced CT scans were compared. Results: The correlation between concentration and the percentage of mean dose of the tumor volume was significant in 2 of the tumor sizes. The differences in the mean doses of the 2 plans were examined and more than 3% increase was observed in higher concentrations of the contrast media. Conclusions: According to this study, the suitable concentration of the contrast media administered and the CT scan energy should be considered. This would help to decrease the discrepancies between the calculated and delivered dose in radiotherapy treatments to a clinically acceptable level. The importance of time delays for CT scans after administration of the contrast media is emphasized.